AcelRx Pharmaceuticals
ACRX
$0.86
Share price
7.50%
Change (1 day)
40.98%
Change (1 year)
Categories
AcelRx Pharmaceuticals (ACRX) - P/B ratio
P/B ratio as of April 2024 : 1.03
According to AcelRx Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 1.03.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
AcelRx Pharmaceuticals - P/B ratio (from 2011 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.8834 | 14.46% |
| 2022-12-31 | 0.7718 | -141.44% |
| 2021-12-31 | -1.86 | -7.46% |
| 2020-12-31 | -2.01 | -50.36% |
| 2019-12-31 | -4.05 | -109.48% |
| 2018-12-31 | 42.8 | -1632.1% |
| 2017-12-31 | -2.79 | -87.36% |
| 2016-12-31 | -22.1 | -519.56% |
| 2015-12-31 | 5.26 | -16.52% |
| 2014-12-31 | 6.31 | -5.26% |
| 2013-12-31 | 6.66 | 42.7% |
| 2012-12-31 | 4.66 | 117% |
| 2011-12-31 | 2.15 | |
| 2010-12-31 | N/A | |
| 2009-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Cara Therapeutics
CARA | 0.6606 | -36.08% | 🇺🇸 USA |